Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

BAFF receptor (CT) BR3 polyclonal antibody

ADI-905-305-100 100 µg 385.00 USD
Do you need bulk/larger quantities?

Product Specification

Alternative Name:BlySR3, TNFRSF 13C, CD268
Immunogen:Synthetic peptide corresponding to the sequence near the C-terminus of human BAFF receptor.
UniProt ID:Q96RJ3
Species reactivity:Human, Mouse, Rat
Applications:IHC, WB
Recommended Dilutions/Conditions:Immunohistochemistry (5µg/ml)
Western Blot (2-5µg/ml)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
Purity Detail:Peptide affinity purified.
Formulation:Liquid. In PBS containing 0.02% sodium azide.
Shipping:Shipped on Blue Ice
Long Term Storage:-20°C
Scientific Background:BAFF, or B-cell Activating Factor, is a member of the TNF superfamily also known as BLyS (B Lymphocyte Stimulator), TALL-1 (TNF- and ApoLrelated Leukocyte-expressed Ligand), and THANK (TNF Homologue that Activate Apoptosis, NF-κB and c-jun N-terminal Kinase). BAFF/BLyS was characterized as a B-cell activator since it induced B-cell proliferation and immunoglobulin secretion. Three receptors for BAFF were identified and designated TACI, BCMA, and BAFF-R. BAFF and its receptors are essential for B-cell development, survival, and humoral immune responses.
905-305 WB
Western blot analysis of BAFF Receptor in human (H), mouse (M), and rat (R) spleen tissue lysates with BAFF Receptor antibody at 5µg/ml.
905-305 IHC
Immunohistochemistry analysis of BAFF Receptor in human tonsil tissue with BAFF Receptor antibody at 5µg/ml.
Please mouse over
905-305 WB 905-305 IHC

Product Toolbox


Certificate of Analysis


By target:
BAFF receptor
By biological activity:
BAFF receptor Polyclonal antibody
By catalog section:


Technical Service
Customer Service

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,